Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$11.06 - $14.01 $12,166 - $15,411
-1,100 Reduced 9.02%
11,100 $22,000
Q3 2020

Nov 13, 2020

BUY
$10.26 - $14.55 $3,078 - $4,365
300 Added 2.52%
12,200 $6,000
Q2 2020

Aug 10, 2020

BUY
$7.11 - $13.76 $84,609 - $163,744
11,900 New
11,900 $28,000

Others Institutions Holding ATNX

About Athenex, Inc.


  • Ticker ATNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 156,790,000
  • Market Cap $1.57M
  • Description
  • Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...
More about ATNX
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.